TENAX THERAPEUTICS, INC. — Director's Dealing 2021

Jun 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TENAX THERAPEUTICS, INC. (TENX)
CIK: 0000034956
Period of Report: 2021-06-10

Reporting Person: PROEHL GERALD T (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-10	Stock Option (right to buy)	$2.00	A	5000	Acquired	2031-06-10	Common Stock (5000)	Direct